Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Cronos Group Is Sliding Today

By Cory Renauer - Updated Apr 16, 2019 at 9:31AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors are taking a closer look at yesterday's not-so-great earnings report.

What happened

Shares of Cronos Group (CRON -0.88%), a Canadian cannabis producer, are sliding after several analysts issued downgrades in response to yesterday's earnings call. Investors worried that Canada's government-run cannabis program isn't going anywhere fast have driven the stock 12.5% lower this morning, and it has lost 9.1% as of 2:26 p.m. EDT on Wednesday.

So what

Several analysts, including Canaccord's Matt Bromley, downgraded Cronos Group after the company reported uninspiring results during the last three months of 2018. Compared to its peers, Cronos really didn't do too badly. Unfortunately, the competition set a pretty low bar.

Canadian maple leaf surrounded by cannabis.

Image source: Getty Images.

Cronos was the first licensed cannabis producer to list its shares on a major U.S. stock exchange, but now it's the smallest by sales. Revenue rose 49% from the previous quarter to just 5.6 million Canadian dollars.

That wasn't nearly enough to cover expenses, and operations lost CA$21.5 million, an unacceptable 137% of revenue recorded during the fourth quarter.

Check out the latest earnings call transcript for Cronos Group.

Now what

Statistics Canada reported total sales of licensed cannabis in January were lower than a month earlier. If February's sales figures aren't a lot better than January's, Cronos Group and its peers could be in a lot of trouble.

International sales aren't significant enough to mention yet, which means Cronos is depending on its domestic market to fund operations through the next few years without asking investors for another handout. That's going to be a problem, because the domestic market reached an annualized CA$1.2 billion in the fourth quarter, and it doesn't seem to be getting much larger. Remember, Cronos needs to share that pie with half a dozen larger licensed producers plus at least a hundred smaller ones.

Somehow, Cronos Group still has a $3.3 billion market cap. Unless another company like Altria or Constellation Brands makes an irrational decision and starts throwing money at Cronos, it won't stay that high much longer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Cronos Group Stock Quote
Cronos Group
$3.39 (-0.88%) $0.03

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/22/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.